Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Choi

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Human Molecular Genetics|January 5, 2010
Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1Christina A Gurnett, David M Desruisseau, Kevin McCall, et al.
International Journal for Parasitology. Drugs and Drug Resistance|June 25, 2024
Efficacy of the bumped kinase inhibitor BKI-1708 against the cyst-forming apicomplexan parasites Toxoplasma gondii and Neospora caninum in vitro and in experimentally infected miceMaria Cristina Ferreira de Sousa, Dennis Imhof, Kai Pascal Alexander Hänggeli, et al.
Veterinary Parasitology|January 22, 2016
Bumped kinase inhibitor prohibits egression in Babesia bovisMonica J Pedroni, Rama Subba Rao Vidadala, Ryan Choi, et al.
Nature Chemistry|October 3, 2025
Bottom-up approach to making larger hydrocarbon molecules capable of optical cyclingGuanming Lao, Taras Khvorost, Antonio Macias, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2017
Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosisJoachim Müller, Adriana Aguado-Martínez, Luis-Miguel Ortega-Mora, et al.
ACS Infectious Diseases|February 10, 2021
Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Rama S R Vidadala, et al.
Gut|May 15, 2021
Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web toolKit Curtius, Misha Kabir, Ibrahim Al Bakir, et al.
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift AssaysSuzanne Scheele, Jennifer A Geiger, Amy E DeRocher, et al.
The Journal of Infectious Diseases|June 11, 2019
P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite CryptosporidiumSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Human Molecular Genetics|January 5, 2010
Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1Christina A Gurnett, David M Desruisseau, Kevin McCall, et al.
International Journal for Parasitology. Drugs and Drug Resistance|June 25, 2024
Efficacy of the bumped kinase inhibitor BKI-1708 against the cyst-forming apicomplexan parasites Toxoplasma gondii and Neospora caninum in vitro and in experimentally infected miceMaria Cristina Ferreira de Sousa, Dennis Imhof, Kai Pascal Alexander Hänggeli, et al.
Veterinary Parasitology|January 22, 2016
Bumped kinase inhibitor prohibits egression in Babesia bovisMonica J Pedroni, Rama Subba Rao Vidadala, Ryan Choi, et al.
Nature Chemistry|October 3, 2025
Bottom-up approach to making larger hydrocarbon molecules capable of optical cyclingGuanming Lao, Taras Khvorost, Antonio Macias, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2017
Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosisJoachim Müller, Adriana Aguado-Martínez, Luis-Miguel Ortega-Mora, et al.
ACS Infectious Diseases|February 10, 2021
Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Rama S R Vidadala, et al.
Gut|May 15, 2021
Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web toolKit Curtius, Misha Kabir, Ibrahim Al Bakir, et al.
Journal of Medicinal Chemistry|March 5, 2019
Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyWenlin Huang, Matthew A Hulverson, Ryan Choi, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift AssaysSuzanne Scheele, Jennifer A Geiger, Amy E DeRocher, et al.
The Journal of Infectious Diseases|June 11, 2019
P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite CryptosporidiumSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
Pageof 10